OncoSil Medical Ltd (AU:OSL) has released an update.
Pick the best stocks and maximize your portfolio:
- Discover top-rated stocks from highly ranked analysts with Analyst Top Stocks!
- Easily identify outperforming stocks and invest smarter with Top Smart Score Stocks
OncoSil Medical Ltd has made significant strides in the first quarter of 2024, achieving authorization for funding negotiations in Germany for its OncoSil device, expanding into the Turkish market with a new distributor and a successful first treatment, and initiating a capital raise to garner approximately $7.1 million. The company has reported a cash balance of $2.930 million at the end of March 2024, with a focus on managing and reducing operational expenditures to extend its financial runway.
For further insights into AU:OSL stock, check out TipRanks’ Stock Analysis page.